Lumasiran for treating primary hyperoxaluria type 1

Supporting evidence

• Evaluation report

• Evaluation consultation 1 committee papers (PDF 7.97 MB)

  Published:

  19 April 2023

• Evaluation consultation 2 committee papers (PDF 1.89 MB)

  Published:

  19 April 2023

• Final evaluation committee papers (PDF 1.6 MB)

  Published:

  19 April 2023